Topical application of activity-based probes for visualization of brain tumor tissue

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Cutter, Jennifer L ^a,e   Cohen, Nathan T ^a,g   Wang, Jing ^a,h   Sloan, Andrew E ^c   Cohen, Alan R ^d,i   Panneerselvam, Ashok ^c,j   Schluchter, Mark ^c   Blum, Galia ^c,k   Bogyo, Matthew ^c   Basilion, James P ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^e

^f United States

^g UNIVERSITY OF VIRGINIA   (United States)

^h HAINAN PROVINCIAL PEOPLE S HOSPITAL   (China)

ⁱ BOSTON CHILDREN S HOSPITAL   (United States)

^j NOVARTIS PHARMA AG   (Switzerland)

^k HEBREW UNIVERSITY OF JERUSALEM   (Israel)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; CYSTEINE CATHEPSIN; FLUORESCENT DYE; GB 119; GB 123; GB 125; PROTEINASE; UNCLASSIFIED DRUG; CYSTEINE; DIAGNOSTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CANCER SURGERY; CELL INFILTRATION; CELL LABELING; CONTROLLED STUDY; FEMALE; FLUORESCENCE; FLUORESCENCE QUENCHING; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMAGE GUIDED SURGERY; MOLECULAR IMAGING; MOUSE; NEUROIMAGING; NONHUMAN; OPTICAL IMAGING PROBE; DIAGNOSTIC IMAGING; INSTRUMENTATION; METABOLISM; METHODOLOGY; PATHOLOGY; PATIENT MONITORING; TOPICAL DRUG ADMINISTRATION; TUMOR CELL LINE;

ANIMALIA;

ADMINISTRATION, TOPICAL; BRAIN NEOPLASMS; CATHEPSINS; CELL LINE, TUMOR; CYSTEINE; DIAGNOSTIC IMAGING; FLUORESCENT DYES; HUMANS; MOLECULAR IMAGING; MONITORING, INTRAOPERATIVE;

EID: 84863263041     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033060     Document Type: Article

References (47)

1. Ries LAG MD, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, et al. (2008) SEER Cancer Statistics Review, 1975-2005: National Cancer Institute.
2. Sawaya R, (2001) Fifty years of neurosurgery argue in favor of glioma resection. Clin Neurosurg 48: 10-19.
3. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, et al. (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. The lancet oncology 7: 392-401.
4. Pichlmeier U, Bink A, Schackert G, Stummer W, (2008) Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 10: 1025-1034.
5. Black PM, Moriarty T, Alexander E 3rd, Stieg P, Woodard EJ, et al. (1997) Development and implementation of intraoperative magnetic resonance imaging and its neurosurgical applications. Neurosurgery 41: 831-842; discussion 842-835.
6. Knauth M, Aras N, Wirtz CR, Dorfler A, Engelhorn T, et al. (1999) Surgically induced intracranial contrast enhancement: potential source of diagnostic error in intraoperative MR imaging. AJNR Am J Neuroradiol 20: 1547-1553.
7. Wirtz CR, Knauth M, Staubert A, Bonsanto MM, Sartor K, et al. (2000) Clinical evaluation and follow-up results for intraoperative magnetic resonance imaging in neurosurgery. Neurosurgery 46: 1112-1120; discussion 1120-1112.
8. Claus EB, Horlacher A, Hsu L, Schwartz RB, Dello-Iacono D, et al. (2005) Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer 103: 1227-1233.
9. Laws ER, Parney IF, Huang W, Anderson F, Morris AM, et al. (2003) Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 99: 467-473.
10. Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, et al. (2008) Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62: 564-576; discussion 564-576.
11. McPherson CM, Sawaya R, (2005) Technologic advances in surgery for brain tumors: tools of the trade in the modern neurosurgical operating room. J Natl Compr Canc Netw 3: 705-710.
12. Keles GE, Anderson B, Berger MS, (1999) The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surg Neurol 52: 371-379.
13. van den Bent MJ, Stupp R, Mason Wea, (2005) Impact of the extent of resection on overall survival in newly diagnosed glioblastoma after chemo-irradiation with temozolamide: further analysis of EORTC study 26981. Eur J Cancer Suppl 3: 134.
14. Mohamed MM, Sloane BF, (2006) Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer 6: 764-775.
15. Joyce JA, Hanahan D, (2004) Multiple roles for cysteine cathepsins in cancer. Cell Cycle 3: 1516-1619.
16. Gocheva V, Zeng W, Ke D, Klimstra D, Reinheckel T, et al. (2006) Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev 20: 543-556.
17. Palermo C, Joyce JA, (2008) Cysteine cathepsin proteases as pharmacological targets in cancer. Trends Pharmacol Sci 29: 22-28.
18. Mikkelsen T, Yan PS, Ho KL, Sameni M, Sloane BF, et al. (1995) Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis. J Neurosurg 83: 285-290.
19. Demchik LL, Sameni M, Nelson K, Mikkelsen T, Sloane BF, (1999) Cathepsin B and glioma invasion. Int J Dev Neurosci 17: 483-494.
20. Strojnik T, Kavalar R, Trinkaus M, Lah TT, (2005) Cathepsin L in glioma progression: comparison with cathepsin B. Cancer Detect Prev 29: 448-455.
21. Levicar N, Kos J, Blejec A, Golouh R, Vrhovec I, et al. (2002) Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients. Cancer Detect Prev 26: 42-49.
22. Levicar N, Nuttall RK, Lah TT, (2003) Proteases in brain tumour progression. Acta Neurochir (Wien) 145: 825-838.
23. Blum G, Mullins SR, Keren K, Fonovic M, Jedeszko C, et al. (2005) Dynamic imaging of protease activity with fluorescently quenched activity-based probes. Nat Chem Biol 1: 203-209.
24. Tung CH, Bredow S, Mahmood U, Weissleder R, (1999) Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging. Bioconjug Chem 10: 892-896.
25. Kircher MF, Mahmood U, King RS, Weissleder R, Josephson L, (2003) A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res 63: 8122-8125.
26. Funovics M, Weissleder R, Tung CH, (2003) Protease sensors for bioimaging. Anal Bioanal Chem 377: 956-963.
27. Kirsch DG, Dinulescu DM, Miller JB, Grimm J, Santiago PM, et al. (2007) A spatially and temporally restricted mouse model of soft tissue sarcoma. Nature medicine 13: 992-997.
28. van Dam GM, Themelis G, Crane LM, Harlaar NJ, Pleijhuis RG, et al. (2011) Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results. Nature medicine 17: 1315-1319.
29. Urano Y, Sakabe M, Kosaka N, Ogawa M, Mitsunaga M, et al. (2011) Rapid cancer detection by topically spraying a gamma-glutamyltranspeptidase-activated fluorescent probe. Science translational medicine 3: 110ra119.
30. Blum G, Weimer RM, Edgington LE, Adams W, Bogyo M, (2009) Comparative Assessment of Substrates and Activity Based Probes as Tools for Non-Invasive Optical Imaging of Cysteine Protease Activity. PLoS Med 4: e6374.
31. Blum G, von Degenfeld G, Merchant MJ, Blau HM, Bogyo M, (2007) Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. Nat Chem Biol 3: 668-677.
32. Sega EI, Low PS, (2008) Tumor detection using folate receptor-targeted imaging agents. Cancer metastasis reviews 27: 655-664.
33. Barker FG, 2nd, Chang SM, Gutin PH, Malec MK, McDermott MW, et al. (1998) Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 42: 709-720; discussion 720-703.
34. De Grand AM, Frangioni JV, (2003) An operational near-infrared fluorescence imaging system prototype for large animal surgery. Technol Cancer Res Treat 2: 553-562.
35. Haglund MM, Berger MS, Hochman DW, (1996) Enhanced optical imaging of human gliomas and tumor margins. Neurosurgery 38: 308-317.
36. Weissleder R, Ntziachristos V, (2003) Shedding light onto live molecular targets. Nat Med 9: 123-128.
37. Gao CY, Stepp MA, Fariss R, Zelenka P, (2004) Cdk5 regulates activation and localization of Src during corneal epithelial wound closure. J Cell Sci 117: 4089-4098.
38. Veiseh M, Gabikian P, Bahrami SB, Veiseh O, Zhang M, et al. (2007) Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Res 67: 6882-6888.
39. Alencar H, Funovics MA, Figueiredo J, Sawaya H, Weissleder R, et al. (2007) Colonic adenocarcinomas: near-infrared microcatheter imaging of smart probes for early detection-study in mice. Radiology 244: 232-238.
40. Upadhyay R, Sheth RA, Weissleder R, Mahmood U, (2007) Quantitative real-time catheter-based fluorescence molecular imaging in mice. Radiology 245: 523-531.
41. Figueiredo JL, Alencar H, Weissleder R, Mahmood U, (2006) Near infrared thoracoscopy of tumoral protease activity for improved detection of peripheral lung cancer. Int J Cancer 118: 2672-2677.
42. Lee BT, Matsui A, Hutteman M, Lin SJ, Winer JH, et al. (2010) Intraoperative near-infrared fluorescence imaging in perforator flap reconstruction: current research and early clinical experience. Journal of reconstructive microsurgery 26: 59-65.
43. Troyan SL, Kianzad V, Gibbs-Strauss SL, Gioux S, Matsui A, et al. (2009) The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Annals of surgical oncology 16: 2943-2952.
44. Razansky D, Deliolanis N, Vinegoni C, Ntziachristos V, (2012) Deep Tissue Optical and Optoacoustic Molecular Imaging Technologies for Small Animal Research and Drug Discovery. Current pharmaceutical biotechnology.
45. Ntziachristos V, (2010) Going deeper than microscopy: the optical imaging frontier in biology. Nature methods 7: 603-614.
46. Ntziachristos V, (2011) Clinical translation of optical and optoacoustic imaging. Philosophical transactions Series A, Mathematical, physical, and engineering sciences 369: 4666-4678.
47. Abe T, Wakimoto H, Bookstein R, Maneval DC, Chiocca EA, et al. (2002) Intra-arterial delivery of p53-containing adenoviral vector into experimental brain tumors. Cancer Gene Ther 9: 228-235.